These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27525719)

  • 41. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
    Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
    Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Protein Interaction between β-Catenin and Dnmt1 Regulates Wnt Signaling and DNA Methylation in Colorectal Cancer Cells.
    Song J; Du Z; Ravasz M; Dong B; Wang Z; Ewing RM
    Mol Cancer Res; 2015 Jun; 13(6):969-81. PubMed ID: 25753001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells.
    Dong HJ; Jang GB; Lee HY; Park SR; Kim JY; Nam JS; Hong IS
    Sci Rep; 2016 Mar; 6():22966. PubMed ID: 26965643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
    Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
    Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Wnt2 complements Wnt/β-catenin signaling in colorectal cancer.
    Jung YS; Jun S; Lee SH; Sharma A; Park JI
    Oncotarget; 2015 Nov; 6(35):37257-68. PubMed ID: 26484565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition.
    Laumet G; Garriga J; Chen SR; Zhang Y; Li DP; Smith TM; Dong Y; Jelinek J; Cesaroni M; Issa JP; Pan HL
    Nat Neurosci; 2015 Dec; 18(12):1746-55. PubMed ID: 26551542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of metastatic site on the expression of CEA and cellular localization of β-catenin in colorectal cancer.
    Rao US; Hoerster NS; Thirumala S; Rao PS
    J Gastroenterol Hepatol; 2013 Mar; 28(3):505-12. PubMed ID: 23216017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The acquisition of cancer stem cell-like properties and neoplastic transformation of human keratinocytes induced by arsenite involves epigenetic silencing of let-7c via Ras/NF-κB.
    Jiang R; Li Y; Zhang A; Wang B; Xu Y; Xu W; Zhao Y; Luo F; Liu Q
    Toxicol Lett; 2014 Jun; 227(2):91-8. PubMed ID: 24704393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression.
    Mir R; Pradhan SJ; Patil P; Mulherkar R; Galande S
    Oncogene; 2016 Mar; 35(13):1679-91. PubMed ID: 26165840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.
    Paschall AV; Yang D; Lu C; Choi JH; Li X; Liu F; Figueroa M; Oberlies NH; Pearce C; Bollag WB; Nayak-Kapoor A; Liu K
    J Immunol; 2015 Aug; 195(4):1868-82. PubMed ID: 26136424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional genetic screen identifies ITPR3/calcium/RELB axis as a driver of colorectal cancer metastatic liver colonization.
    Moy RH; Nguyen A; Loo JM; Yamaguchi N; Kajba CM; Santhanam B; Ostendorf BN; Wu YG; Tavazoie S; Tavazoie SF
    Dev Cell; 2022 May; 57(9):1146-1159.e7. PubMed ID: 35487218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway.
    Ogawa T; Hirohashi Y; Murai A; Nishidate T; Okita K; Wang L; Ikehara Y; Satoyoshi T; Usui A; Kubo T; Nakastugawa M; Kanaseki T; Tsukahara T; Kutomi G; Furuhata T; Hirata K; Sato N; Mizuguchi T; Takemasa I; Torigoe T
    Oncotarget; 2017 Dec; 8(68):112550-112564. PubMed ID: 29348846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma.
    Zhang XY; Rajagopalan D; Chung TH; Hooi L; Toh TB; Tian JS; Rashid MBMA; Sahib NRBM; Gu M; Lim JJ; Wang W; Chng WJ; Jha S; Chow EK
    Exp Hematol Oncol; 2020; 9():8. PubMed ID: 32477831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance.
    Ghatak S; Hascall VC; Karamanos N; Markwald RR; Misra S
    Front Oncol; 2022; 12():906415. PubMed ID: 35982950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity.
    Mair B; Konopka T; Kerzendorfer C; Sleiman K; Salic S; Serra V; Muellner MK; Theodorou V; Nijman SM
    PLoS Genet; 2016 Sep; 12(9):e1006279. PubMed ID: 27588951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging role of G9a in cancer stemness and promises as a therapeutic target.
    Haebe JR; Bergin CJ; Sandouka T; Benoit YD
    Oncogenesis; 2021 Nov; 10(11):76. PubMed ID: 34775469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pedf derived peptides affect colorectal cancer cell lines resistance and tumour re-growth capacity.
    Honrubia-Gómez P; López-Garrido MP; Gil-Gas C; Sánchez-Sánchez J; Alvarez-Simon C; Cuenca-Escalona J; Perez AF; Arias E; Moreno R; Sánchez-Sánchez F; Ramirez-Castillejo C
    Oncotarget; 2019 Apr; 10(31):2973-2986. PubMed ID: 31105879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retraction: G9a/RelB regulates self-renewal and function of colon-cancer-initiating cells by silencing Let-7b and activating the K-RAS/β-catenin pathway.
    Cha ST; Tan CT; Chang CC; Chu CY; Lee WJ; Lin BZ; Lin MT; Kuo ML
    Nat Cell Biol; 2016 Dec; 19(1):76. PubMed ID: 28008183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.